17
Variant
No.
AASeq KD
(nM)
ka kd
Fab
Net
Charge
FvCSP HISum Cam
Sol
Min
NetMHC
(%
Rank)
No. min
NetMHC
(%
Rank)
Avg
NetMHC
(% Rank)
Max
1/
MeanIC50
Max
1/
MedianIC50
Max
No.
Binders
LD
1 CSRWKGDGFYEHDYW 0.33 1.38E+05 4.61E-05 6.04 9.13 0.57 0.77 6 2 71.3 2.72E-04 3.57E-04 1 3
2 CSRWPGPGMYTNDYW 0.38 2.67E+05 1.02E-04 6.19 9.58 0.53 0.68 6 2 77.6 2.31E-04 2.48E-04 1 5
3 CSRWPGPGMYANDYW 0.39 2.40E+05 9.33E-05 6.19 9.58 0.63 0.69 6 2 75.6 2.48E-04 2.61E-04 1 4
4 CSRWRGDGFYEHDYW 0.49 1.89E+05 9.28E-05 6.04 9.13 0.54 0.78 6 2 69.2 2.84E-04 3.57E-04 1 3
5 CSRWREPGFYEHDYW 0.64 1.49E+05 9.53E-05 6.07 9.22 0.53 0.79 6 2 69.3 3.04E-04 4.80E-04 1 5
6 CSRWKEPGFYEHDYW 0.77 9.59E+04 7.41E-05 6.07 9.22 0.56 0.78 6 2 71.0 2.72E-04 4.19E-04 1 5
7 CSRWKDPGFYEHDYW 0.77 1.16E+05 8.98E-05 6.04 9.13 0.55 0.77 6 2 73.2 2.72E-04 3.57E-04 1 5
8 CSRYGPPGMYTNDYW 0.96 2.94E+05 2.83E-04 6.19 9.58 0.41 0.70 6 2 76.8 2.51E-04 2.55E-04 1 6
9 CSRWRDDGLYAHDYW 1.01 1.83E+05 1.85E-04 6.01 9.03 0.56 0.75 6 2 69.3 2.86E-04 3.62E-04 1 4
10 CSRWNDRGFYEHDYW 1.07 9.01E+04 9.62E-05 6.04 9.12 0.52 0.74 6 2 70.1 2.89E-04 3.85E-04 1 5
11 CSRWPGGGMYANDYW 1.15 2.72E+05 3.12E-04 6.19 9.58 0.68 0.68 6 2 75.7 2.48E-04 2.61E-04 1 4
12 CSRWGGPGMYTNDYW 1.32 3.07E+05 4.05E-04 6.19 9.58 0.57 0.66 6 2 77.9 2.31E-04 2.48E-04 1 4
13 CSRWRDPGFYEHDYW 1.37 2.00E+05 2.73E-04 6.04 9.13 0.53 0.79 6 2 71.5 2.84E-04 3.57E-04 1 5
14 CSRWKQDGFYEHDYW 1.44 5.41E+04 7.79E-05 6.04 9.13 0.54 0.76 6 2 70.0 2.72E-04 3.57E-04 1 4
15 CSRYGGPGMYTNDYW 1.57 3.06E+05 4.80E-04 6.19 9.58 0.44 0.69 6 2 77.3 2.51E-04 2.55E-04 1 5
16 CSRYGGDGMYQHDYW 1.77 2.19E+05 3.88E-04 5.99 8.97 0.43 0.69 6 2 78.1 2.52E-04 2.72E-04 1 4
17 CSRYGGTGMYEHDYW 1.83 2.38E+05 4.36E-04 6.02 9.06 0.45 0.72 6 2 74.7 2.51E-04 2.55E-04 1 5
18 CSRYGNGGMYANDYW 2.23 5.54E+05 1.24E-03 6.19 9.58 0.52 0.71 6 2 73.9 2.51E-04 2.61E-04 1 5
19 CSRYGPGGMYEHDYW 2.47 2.87E+05 7.10E-04 6.02 9.06 0.43 0.75 6 2 77.9 2.51E-04 2.55E-04 1 6
20 CSRWGGPGMYEHDYW 2.53 2.01E+05 5.07E-04 6.02 9.06 0.55 0.72 6 2 78.4 2.29E-04 2.47E-04 1 4
21 CSRYRGDGFYEHDYW 2.85 2.49E+05 7.09E-04 6.04 9.13 0.48 0.81 6 2 68.5 3.05E-04 3.57E-04 1 4
22 CSRYGGPGLYANDYW 2.88 2.90E+05 8.35E-04 6.19 9.58 0.71 0.70 6 2 73.3 2.65E-04 2.76E-04 1 4
23 CSRYGGPGMYQNDYW 3.02 2.57E+05 7.76E-04 6.19 9.58 0.42 0.72 6 2 77.5 2.51E-04 2.55E-04 1 5
24 CSRWPQPGMYANDYW 3.02 2.64E+05 7.98E-04 6.19 9.58 0.56 0.68 6 2 73.3 2.71E-04 2.87E-04 1 5
25 CSRYGGPGMYEHDYW 3.12 1.88E+05 5.87E-04 6.02 9.06 0.43 0.76 6 2 78.0 2.51E-04 2.55E-04 1 5
26 CSRYGDPGMYQHDYW 3.31 1.99E+05 6.57E-04 5.99 8.96 0.40 0.69 6 2 77.4 2.52E-04 2.72E-04 1 6
27 CSRYGGPGLYTNDYW 3.32 3.12E+05 1.04E-03 6.19 9.58 0.60 0.69 6 2 75.6 2.51E-04 2.60E-04 1 5
28 CSRYGPGGLYTNDYW 3.45 3.39E+05 1.17E-03 6.19 9.58 0.60 0.69 6 2 75.6 2.51E-04 2.60E-04 1 6
29 CSRYGGPGLYEHDYW 3.51 1.90E+05 6.67E-04 6.02 9.06 0.59 0.75 6 2 76.6 2.51E-04 2.55E-04 1 5
30 CSRWGNPGMYANDYW 3.65 3.44E+05 1.26E-03 6.19 9.58 0.59 0.68 6 2 73.3 2.48E-04 2.61E-04 1 4
31 CSRWRHDGFYENDYW 3.71 9.77E+04 3.62E-04 6.04 9.12 0.52 0.80 6 2 68.3 2.84E-04 4.03E-04 1 4
32 CSRYGPGGMYANDYW 3.85 3.50E+05 1.35E-03 6.19 9.58 0.55 0.71 6 2 75.0 2.51E-04 2.61E-04 1 5
33 CSRWGNGGMYANDYW 3.94 5.81E+05 2.29E-03 6.19 9.58 0.63 0.67 6 2 74.3 2.48E-04 2.61E-04 1 4
34 CSRYGERGFYEHDYW 4.02 2.48E+05 9.97E-04 6.07 9.22 0.49 0.76 6 2 68.9 2.87E-04 3.94E-04 1 5
35 CSRYGGNGMYTNDYW 4.02 3.51E+05 1.41E-03 6.19 9.58 0.44 0.69 6 2 75.7 2.51E-04 2.55E-04 1 5
36 CSRYGSPGMYTNDYW 4.40 3.49E+05 1.54E-03 6.19 9.58 0.43 0.69 6 2 72.8 2.77E-04 3.23E-04 1 6
37 CSRYGQPGMYTNDYW 4.65 3.80E+05 1.77E-03 6.19 9.58 0.41 0.69 6 2 74.9 2.55E-04 3.17E-04 1 6
38 CSRYGEPGMYQHDYW 4.79 2.43E+05 1.16E-03 6.02 9.06 0.41 0.69 6 2 75.4 2.52E-04 3.22E-04 1 6
39 CSRWGGNGMYANDYW 4.87 4.01E+05 1.95E-03 6.19 9.58 0.63 0.67 6 2 73.7 2.48E-04 2.61E-04 1 3
40 CSRYGDRGFYEHDYW 5.35 3.11E+05 1.66E-03 6.04 9.13 0.48 0.76 6 2 71.4 2.60E-04 3.65E-04 1 5
41 CSRYGPNGLYANDYW 5.47 3.63E+05 1.99E-03 6.19 9.58 0.62 0.71 6 2 70.3 2.65E-04 3.08E-04 1 5
42 CSRYGGNGMYQNDYW 5.86 2.83E+05 1.66E-03 6.19 9.58 0.42 0.72 6 2 76.3 2.51E-04 2.55E-04 1 5
43 CSRYGNPGMYQNDYW 6.27 5.19E+05 3.26E-03 6.19 9.57 0.40 0.73 6 2 75.6 2.51E-04 2.56E-04 1 6
44 CSRYGQPGMYANDYW 6.86 4.23E+05 2.90E-03 6.19 9.58 0.49 0.71 6 2 72.4 2.55E-04 3.17E-04 1 5
45 CSRYSGPGMYANDYW 7.14 2.78E+05 1.99E-03 6.19 9.58 0.51 0.71 6 2 71.1 2.92E-04 2.98E-04 1 5
46 CSRYGSNGMYQNDYW 7.31 4.17E+05 3.04E-03 6.19 9.57 0.41 0.72 6 2 71.8 2.81E-04 3.56E-04 1 6
47 CSRYGGNGMYANDYW 7.68 4.42E+05 3.39E-03 6.19 9.58 0.52 0.71 6 2 73.0 2.51E-04 2.61E-04 1 4
48 CSRWERPGLYEHDYW 8.70 2.95E+05 2.57E-03 6.07 9.22 0.52 0.83 6 2 70.5 3.86E-04 6.67E-04 1 6
49 CSRWRPDGFYEHDYW 9.12 2.94E+05 2.68E-03 6.04 9.13 0.53 0.79 6 2 69.0 2.99E-04 3.89E-04 1 4
50 CSRWREPGLYEHDYW 11.40 1.37E+05 1.56E-03 6.07 9.22 0.52 0.85 6 2 71.7 3.11E-04 4.93E-04 1 6
51 CSRYGNPGMYEHDYW 11.69 1.81E+05 2.11E-03 6.02 9.06 0.41 0.76 6 2 76.2 2.51E-04 2.56E-04 1 6
52 CSRWDRPGLYEHDYW 11.81 6.07E+04 7.17E-04 6.04 9.13 0.51 0.81 6 2 74.0 2.87E-04 3.23E-04 1 6
53 CSRWKEPGLYEHDYW 13.28 9.14E+04 1.21E-03 6.07 9.22 0.54 0.83 6 2 73.5 2.72E-04 4.33E-04 1 6
54 CSRYGQPGMYEHDYW 13.32 1.34E+05 1.79E-03 6.02 9.06 0.41 0.75 6 2 75.6 2.55E-04 3.17E-04 1 6
55 CSRYGQPGLYEHDYW 18.34 7.53E+04 1.38E-03 6.02 9.06 0.53 0.74 6 2 74.3 2.70E-04 3.60E-04 1 6
WT-Tra CSRWGGDGFYAMDYW 0.40 2.51E+05 1.01E-04 5.21 6.61 0.92 0.49 5.5 2 60.6 5.50E-04 1.05E-03 1 0
Supplementary Table 6: Calculated parameters for the 60 identiﬁed variants
55 unique CDRH3 sequences were identiﬁed after transfecting a single oligonucleotide pool. These
sequences were ranked at the top after in silico ﬁltering (Figure 5). The table provides each sequence and
the value for each computationally calculated parameter. Diﬀerences in the amino acid sequence when
compared to the Trastuzumab sequence are highlighted in red bold.